Prior Ibrutinib May Improve CAR-T Efficacy in Rare Lymphoma
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Prior exposure to ibrutinib (Imbruvica) in patients with mantle cell lymphoma (MCL) was associated with improved efficacy following treatment with chimeric antigen receptor (CAR) T-cell therapy brexucabtagene autoleucel…
:max_bytes(150000):strip_icc()/Health-GettyImages-2246731267-59fdd86d80b44c95994571d4edcb3b6a.jpg?w=390&resize=390,220&ssl=1 "Eat Dates Before a Workout, Choose Sweet Potatoes for Better Blood Sugar—and 3 More Health Hacks to Try This Week")
